Affiance Financial’s AbbVie ABBV Stock Holding History

Affiance Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$684K	Sell	2,720 -26	-0.9%	-$5.59K	0.1%	66
2026 Q1	$597K	Hold	2,746	–	–	0.1%	65
2025 Q4	$627K	Sell	2,746 -79	-3%	-$18K	0.1%	63
2025 Q3	$654K	Buy	2,825 +11	+0.4%	+$2.24K	0.12%	61
2025 Q2	$522K	Buy	2,814 +26	+0.9%	+$4.83K	0.11%	65
2025 Q1	$584K	Sell	2,788 -178	-6%	-$34.6K	0.14%	61
2024 Q4	$527K	Sell	2,966 -53	-2%	-$9.74K	0.13%	66
2024 Q3	$596K	Hold	3,019	–	–	0.14%	61
2024 Q2	$518K	Hold	3,019	–	–	0.14%	62
2024 Q1	$550K	Hold	3,019	–	–	0.15%	63
2023 Q4	$468K	Hold	3,019	–	–	0.14%	67
2023 Q3	$450K	Sell	3,019 -98	-3%	-$14.4K	0.23%	66
2023 Q2	$420K	Hold	3,117	–	–	0.2%	74
2023 Q1	$497K	Hold	3,117	–	–	0.26%	64
2022 Q4	$504K	Buy	3,117 +41	+1%	+$6.29K	0.2%	71
2022 Q3	$413K	Hold	3,076	–	–	0.23%	54
2022 Q2	$471K	Sell	3,076 -800	-21%	-$122K	0.25%	55
2022 Q1	$628K	Sell	3,876 -9	-0.2%	-$1.31K	0.31%	48
2021 Q4	$526K	Hold	3,885	–	–	0.22%	70
2021 Q3	$419K	Hold	3,885	–	–	0.18%	79
2021 Q2	$438K	Hold	3,885	–	–	0.19%	78
2021 Q1	$420K	Hold	3,885	–	–	0.19%	77
2020 Q4	$416K	Hold	3,885	–	–	0.22%	73
2020 Q3	$340K	Hold	3,885	–	–	0.2%	71
2020 Q2	$381K	Buy	3,885 +25	+0.6%	+$2.2K	0.21%	64
2020 Q1	$294K	Sell	3,860 -11	-0.3%	-$937	0.2%	65
2019 Q4	$343K	Sell	3,871 -200	-5%	-$16.6K	0.19%	70
2019 Q3	$308K	Hold	4,071	–	–	0.19%	74
2019 Q2	$296K	Sell	4,071 -91	-2%	-$7.15K	0.18%	76
2019 Q1	$335K	Hold	4,162	–	–	0.21%	70
2018 Q4	$384K	Hold	4,162	–	–	0.25%	61
2018 Q3	$394K	Hold	4,162	–	–	0.26%	59
2018 Q2	$386K	Hold	4,162	–	–	0.3%	61
2018 Q1	$394K	Hold	4,162	–	–	0.35%	49
2017 Q4	$403K	Sell	4,162 -11	-0.3%	-$1.04K	0.3%	51
2017 Q3	$371K	Sell	4,173 -200	-5%	-$15.2K	0.3%	51
2017 Q2	$317K	Hold	4,373	–	–	0.25%	57
2017 Q1	$285K	Buy	4,373 +83	+2%	+$5.22K	0.22%	62
2016 Q4	$269K	Hold	4,290	–	–	0.22%	70
2016 Q3	$271K	Hold	4,290	–	–	0.22%	68
2016 Q2	$266K	Sell	4,290 -5	-0.1%	-$305	0.23%	71
2016 Q1	$245K	Sell	4,295 -380	-8%	-$21.2K	0.23%	77
2015 Q4	$277K	Sell	4,675 -387	-8%	-$22.3K	0.28%	65
2015 Q3	$275K	Sell	5,062 -87	-2%	-$5.66K	0.34%	63
2015 Q2	$346K	Sell	5,149 -80	-2%	-$5.22K	0.44%	61
2015 Q1	$306K	Sell	5,229 -49	-0.9%	-$2.96K	0.47%	62
2014 Q4	$345K	Buy	+5,278	New	+$333K	0.61%	47

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Affiance Financial's ABBV Position: Q2 2026 in Review

Affiance Financial reduced its AbbVie (ABBV) stake by 0.95% in Q2 2026, selling an estimated $5.59K and leaving 2,720 shares worth $684K. The position accounts for 0.1% of the portfolio, ranked #66.

Affiance Financial first reported a position in ABBV in Q4 2014 and has held it in 47 quarters since. 2,089 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Affiance Financial held 2,720 shares of AbbVie worth $684K as of Q2 2026.
Affiance Financial sold 26 AbbVie shares in Q2 2026, an estimated $5.59K.
AbbVie made up 0.1% of Affiance Financial's portfolio in Q2 2026, its #66 holding.
Affiance Financial first reported a position in AbbVie in Q4 2014 and has held it in 47 quarters since.
2,089 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Affiance Financial's 13F filing for Q2 2026, filed 9 Jul 2026.